ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0187

Message Testing in Online Recruitment Advertisements for a National Rheumatoid and Psoriatic Arthritis Study

Matthew Kearney1, Sarah Hopkins Gillespie1, Stephanie Chen1, Tyler Cavin2, Christine Lindsay3, Christopher Ritchlin4, Jennifer Seifert5, Susan Goodman6, Jessica Fishman1 and Alexis Ogdie7, 1University of Pennsylvania, Philadelphia, PA, 2University of Rochester, Rochester, NY, 3Self, prosper, TX, 4University of Rochester Medical Center, Canandaigua, NY, 5University of Colorado and Oklahoma Medical Research Foundation, Aurora, CO, 6Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 7Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Wilmington, DE

Meeting: ACR Convergence 2025

Keywords: rheumatoid arthritis, spondyloarthritis, Surveys

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0175–0198) Health Services Research Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Study recruitment procedures have increasingly included paid advertisements using social media. However, it is unclear which types of message framing will be the most effective for recruitment. The most common types of messages use an altruistic messages (contribute to the study out of a desire to help others) or simple informational message. We aimed to compare the effectiveness of two social media message frames – altruism and empowerment – versus attention-matched control in recruiting participants into the Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases (AMP AIM) study, a multi-site study focused on rheumatoid arthritis, psoriatic arthritis, and psoriasis.

Methods: Between September 2024 and February 2025, we posted three Facebook advertisements to recruit study participants. Ads featured the question “Do you have RHEUMATOID ARTHRITIS or PSORIATIC ARTHRITIS?” and used one of three messages: 1) Altruism (“Make a difference by joining the arthritis study!”); 2) Empowerment (“Become a partner. Your voice matters!”); and 3) Attention-matched control (“Consider joining the arthritis study,”). Ads were linked to recruitment websites with matching messages. After pilot testing with altruism ads to focus the scope of impressions, all three ad sets were run concurrently. Facebook users randomly received one of the three ads, but not multiple. Outcomes included impressions (ad views), clicks, engagement (website visitors), and completed submissions. Regression modeling evaluated predictors of completed submissions and website visits. Analyses were conducted using StataSE (version 15).

Results: Over 39 total ad-days (pilot phase=18 days; final phase=21 days, 7 days/ad type), AMP AIM recruitment advertisements collectively generated 1,332,969 views and reached 617,206 unique Facebook users. Across both phases, 13 individuals submitted their information to learn more about the study through the AMP AIM website. Although altruism ads received 7 submissions, the most of any ad group, these submissions were all during the pilot phase. During the final phase when all three ads were run concurrently, all 6 submissions received were from individuals shown the attention-matched control ads – and zero from the altruism or empowerment ads. However, when compared to the attention-matched control ads and after controlling for study phase, regression modelling suggested that both the empowerment and altruism ads received significantly more Facebook impressions (p< .001), more ad clicks (p< .001), and more AMP AIM website visits (p=.017).

Conclusion: Message framing significantly affects attention, engagement, and recruitment. We learned that altruism and empowerment frames increased impressions and clicks but, ultimately, did not improve recruitment. All submissions during the final phase came from attention-matched control ads, suggesting simpler messages may better prompt action. In addition, traditional engagement metrics alone may not fully capture recruitment effectiveness. Additional research to compare these and other message frames among additional subpopulations could help to better inform effective strategies for recruitment.

Supporting image 1


Disclosures: M. Kearney: None; S. Hopkins Gillespie: None; S. Chen: None; T. Cavin: None; C. Lindsay: None; C. Ritchlin: AbbVie, 2, Amgen, 2, Bristol-Myers Squibb(BMS), 2, Eli Lilly, 2, Janssen, 2, 5, MoonLake Pharma, 2, Novartis, 2, 5, Solara, 2, UCB, 2; J. Seifert: None; S. Goodman: Johnson and Johnson, 2, Novartis, 5, Pfizer, 2; J. Fishman: None; A. Ogdie: AbbVie, 5, Amgen, 5, 11, Bristol Myers Squibb, 5, Celgene, 5, CorEvitas, 2, Eli Lilly, 5, Novartis, 5, 11, Pfizer, 5, 11.

To cite this abstract in AMA style:

Kearney M, Hopkins Gillespie S, Chen S, Cavin T, Lindsay C, Ritchlin C, Seifert J, Goodman S, Fishman J, Ogdie A. Message Testing in Online Recruitment Advertisements for a National Rheumatoid and Psoriatic Arthritis Study [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/message-testing-in-online-recruitment-advertisements-for-a-national-rheumatoid-and-psoriatic-arthritis-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/message-testing-in-online-recruitment-advertisements-for-a-national-rheumatoid-and-psoriatic-arthritis-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology